SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001628280-22-018767
Filing Date
2022-07-11
Accepted
2022-07-11 06:16:31
Documents
1
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_165753457810786.html 4/A  
1 FORM 4/A wf-form4a_165753457810786.xml 4/A 5709
  Complete submission text file 0001628280-22-018767.txt   7066
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 BC V8Z7X8
Business Address
Jayne David R.W. (Reporting) CIK: 0001838242 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36421 | Film No.: 221075840